Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 80 shares at $28.00 ($2K) on 2023-11-03, disclosed to the SEC on 2023-11-07.
Scheduled sale ($2k) by EVP, Head of North America under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RYTM | SELL | 2025-02-14 | $240K | — | Filing → |
| RYTM | SELL | 2025-02-11 | $611K | — | Filing → |
| RYTM | SELL | 2025-02-07 | $359K | — | Filing → |